THE Therapeutic Goods
Administration has announced that
effective 01 Nov it will publish the
outcome of “certain investigations
into complaints about advertising”
which have been referred by the
Complaints Resolution Panel.
The TGA says the move aims to
provide guidance to advertisers on
how the Regulations are interpreted
“and also act as an information
resource for advertisers, consumers
and the media on decision making
and actions taken by the TGA in
advertising casewordk”.
Currently the outcome of
complaints are listed in a register at
www.tgacrp.com.au, and where a
person fails to acknowledge or act
on a determination by the panel,
the complaint may be referred to
the TGA for follow-up action.
So-called ‘Regulation 9 Orders’
by the TGA make the advertisers
withdraw advertisments and publish
a retraction or correction, and n
future they will be detailed on the
TGA website at www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Nov 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Nov 10
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.